Inactive Instrument

News Mateon Therapeutics, Inc. Other OTC

Equities

MATN

US57667K1097

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING	30/05	AQ
ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING	20/05	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024	08/05	AQ
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.	29/04	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/04	CI
Oncotelic Therapeutics, Inc. - Linkage of Cancer and Lupus in Gliomas Patients	26/03	AQ
Linkage of Cancer and Lupus in Gliomas Patients	25/03	AQ
Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	25/03	CI
Invitation to Participate in STOP-PC Clinical Trial	04/03	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024 (Updated)	21/02	AQ
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients	16/01	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12	AQ
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant	18/12	AQ
Oncotelic Therapeutics Announces CEO to Discuss Proprietary AI Technology at Ibero-American Chatbot Summit	29/11	AQ
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.	28/11	AQ
Earnings Flash (OTLC) ONCOTELIC THERAPEUTICS Posts Q3 Revenue $70,000	15/11	MT
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results	15/11	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Oncotelic Therapeutics, Inc. announces tranche update	24/23/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mateon Therapeutics, Inc. Other OTC

Equities

MATN

US57667K1097

Summary

Filters